Study Title: Single Arm Phase Ib/II Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer: Big Ten Cancer Research Consortium BTCRC-GU16-043
 

• Status: Completed

• Participating Sites:
  • University of Illinois Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • University of Michigan Rogel Cancer Center
  • Penn State Cancer Institute
  • Rutgers Cancer Institute of New Jersey
• Learn more:
  • clinicaltrials.gov: NCT03308396
  • Big Ten CRC News Release
• Publications and Presentations:
  • Manuscript: Nature Communications February 2024
  • Poster Session: 2021 Genitourinary Cancers Symposium
  • E-Poster: ESMO 2020 Virtual Congress